Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: A secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

Stroke

Volumn 32, Issue 2, 2001, Pages 438-441

  Larrue, Vincent ^a,d   Von Kummer, Rüdiger ^b   Müller, Achim ^c   Bluhmki, Erich ^c  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d CHU RANGUEIL   (France)

Author keywords

Intracerebral hemorrhage; Risk factors; Stroke,acute; Thrombolytic therapy

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; PLACEBO;

ADULT; AGE; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

EID: 0035130531     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.32.2.438     Document Type: Article

References (17)

1. Tissue plasminogen activator for acute ischemic stroke
2. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS)
3. Hemorrhagic transformation in acute ischemic stroke: Potential contributing factors in the European Cooperative Acute Stroke Study
4. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke
5. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
6. Measurements of acute cerebral infarction: A clinical examination scale
7. Hemorrhagic transformation within 36 hours of a cerebral infarct: Relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort
8. Cerebral hemorrhagic infarction at autopsy: Cardiac embolic cause and the relationship to the cause of death
9. Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction
10. Epidemiology and risk factor management
11. Ventricular thrombi and thromboembolism in dilated cardiomyopathy: A prospective follow-up study
12. Acute hypertension but not thrombolysis increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbits
13. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke
14. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke
15. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction: Participants in the national registry of myocardial infarction 2
16. Randomized controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke
17. Risk of aspirin use plus thrombolysis after acute ischaemic stroke: A further MAST-I analysis